FDA Webview
Federal Register
Federal Register Notice: FDA releases a draft guidance on frequently asked questions about commercia...
Federal Register
Federal Register Notice: FDA releases a draft guidance on in vitro diagnostic mulivariate index assa...
Federal Register
Federal Register Notice: FDA determines the regulatory review period for Synercid for purpose of pat...
Federal Register
Federal Register Notice: FDA determines the regulatory review period for Rescula is 1,347 days.
Federal Register
Federal Register notice: FDA posts a list of PMAs that have been approved from 1/1/2021 through 2/14...
Federal Register
Federal Register notice: FDA sends to OMB an information collection extension entitled Food Labeling...
Federal Register
Federal Register notice: FDA submits to OMB an information collection extension entitled Tropical Di...
Federal Register
Federal Register notice: FDA corrects a 5/24 notice on a draft guidance being made available entitle...
Federal Register
Federal Register notice: FDA extends the comment period for a 2/16 notice that requested comments on...
Federal Register
Federal Register notice: FDA makes available a draft guidance entitled Voluntary Consensus Standards...
Federal Register
Federal Register notice: FDA seeks comments on an information collection revision entitled Administr...
Federal Register
Federal Register notice: FDA sends to OMB an information collection extension entitled Guidance on R...
Federal Register
Federal Register notice: FDA renews its Science Advisory Board to the National Center for Toxicologi...
Federal Register
Federal Register notice: FDA makes available a draft guidance for industry entitled Q9(R1) Quality R...
Federal Register
Federal Register notice: FDA makes available a final guidance entitled Technical Performance Assessm...
Federal Register
Federal Register notice: FDA seeks comments on an information collection extension entitled Biologic...
Federal Register
Federal Register notice: FDA seeks comments on an information collection revision entitled Human Dru...
Federal Register
Federal Register notice: CBER announces a voluntary pilot program for sponsors of CBER-regulated 510...
Federal Register
Federal Register notice: FDA makes available a draft guidance entitled Non-Clinical Performance Asse...
Federal Register
Federal Register notice: FDA makes available a final guidance entitled Bladder Cancer: Developing Dr...
